CHARLOTTE, N.C. — cbdMD Inc. acquired substantially all the assets of Bluebird Botanicals in an all-stock transaction. Bluebird, founded in 2012, is among the longest-standing brands in the CBD space.
Previously, Bluebird attracted backing from Juggernaut Capital Partners, a middle-market private equity firm focused on consumer and healthcare investments.
cbdMD expects the all-equity purchase to strengthen its balance sheet by incorporating operational efficiencies through consolidated supply chain, manufacturing, and shared services. In addition, a broader product line and cross-brand distribution opportunities are expected to accelerate revenue growth across both direct-to-consumer and retail channels.
The transaction also included a portfolio of intellectual property including patented-process technologies and regulatory compliance documentation.
